You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Amarin’s Vazkepa secures NICE recommendation

Vazkepa – also known as icosapent ethyl – has been recommended by the National Institute for Health and Care Excellence (NICE) for use across the NHS in England and Wales to reduce cardiovascular disease (CVD) risk.